Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher G Azzoli

Showing results (11-20 of 98) with videos related to

Pageof 10
Sort By:
Journal of Oncology Practice|June 12, 2010
American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non-Small-Cell Lung CancerChristopher G Azzoli, Giuseppe Giaccone, Sarah Temin
Journal of Oncology Practice|May 2, 2012
2011 Focused Update of 2009 American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non-Small-Cell Lung CancerChristopher G Azzoli, Sarah Temin, Giuseppe Giaccone
American Journal of Ophthalmology Case Reports|December 21, 2017
Bilateral acute simultaneous onset anterior uveitis presumed secondary to erlotinib: A report of two casesKendra A Klein, Christopher G Azzoli, Lana M Rifkin
Journal of the National Cancer Institute|June 7, 2007
Cisplatin versus carboplatin for patients with metastatic non-small-cell lung cancer--an old rivalry renewedChristopher G Azzoli, Mark G Kris, David G Pfister
Seminars in Thoracic and Cardiovascular Surgery|November 29, 2008
Therapeutic options for the treatment of advanced lung cancer: introductionValerie W Rusch, Christopher G Azzoli, Kenneth E Rosenzweig
Lung Cancer (Amsterdam, Netherlands)|December 7, 2010
Detection of EGFR mutations in plasma DNA from lung cancer patients by mass spectrometry genotyping is predictive of tumor EGFR status and response to EGFR inhibitorsMarie Brevet, Melissa L Johnson, Christopher G Azzoli, et al.
Cancer Journal (Sudbury, Mass.)|May 28, 2013
Basic mechanisms of therapeutic resistance to radiation and chemotherapy in lung cancerHenning Willers, Christopher G Azzoli, Wil L Santivasi, et al.
Seminars in Thoracic and Cardiovascular Surgery|November 29, 2008
Chemoradiation for unresectable stage III non-small cell lung cancerKatharine A R Price, Christopher G Azzoli, Laurie E Gaspar
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 2, 2008
Molecularly tailored adjuvant chemotherapy for resected non-small cell lung cancer: a time for excitement and equipoiseChristopher G Azzoli, Bernard J Park, William Pao, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 26, 2019
KRAS Mutation for Staging Resected Non-Small Cell Lung CancerMariana Canepa, Nimesh R Patel, Roger C Griffith, et al.
Pageof 10

Showing results (11-20 of 98) with videos related to

Sort By:
Pageof 10
Journal of Oncology Practice|June 12, 2010
American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non-Small-Cell Lung CancerChristopher G Azzoli, Giuseppe Giaccone, Sarah Temin
Journal of Oncology Practice|May 2, 2012
2011 Focused Update of 2009 American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non-Small-Cell Lung CancerChristopher G Azzoli, Sarah Temin, Giuseppe Giaccone
American Journal of Ophthalmology Case Reports|December 21, 2017
Bilateral acute simultaneous onset anterior uveitis presumed secondary to erlotinib: A report of two casesKendra A Klein, Christopher G Azzoli, Lana M Rifkin
Journal of the National Cancer Institute|June 7, 2007
Cisplatin versus carboplatin for patients with metastatic non-small-cell lung cancer--an old rivalry renewedChristopher G Azzoli, Mark G Kris, David G Pfister
Seminars in Thoracic and Cardiovascular Surgery|November 29, 2008
Therapeutic options for the treatment of advanced lung cancer: introductionValerie W Rusch, Christopher G Azzoli, Kenneth E Rosenzweig
Lung Cancer (Amsterdam, Netherlands)|December 7, 2010
Detection of EGFR mutations in plasma DNA from lung cancer patients by mass spectrometry genotyping is predictive of tumor EGFR status and response to EGFR inhibitorsMarie Brevet, Melissa L Johnson, Christopher G Azzoli, et al.
Cancer Journal (Sudbury, Mass.)|May 28, 2013
Basic mechanisms of therapeutic resistance to radiation and chemotherapy in lung cancerHenning Willers, Christopher G Azzoli, Wil L Santivasi, et al.
Seminars in Thoracic and Cardiovascular Surgery|November 29, 2008
Chemoradiation for unresectable stage III non-small cell lung cancerKatharine A R Price, Christopher G Azzoli, Laurie E Gaspar
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 2, 2008
Molecularly tailored adjuvant chemotherapy for resected non-small cell lung cancer: a time for excitement and equipoiseChristopher G Azzoli, Bernard J Park, William Pao, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 26, 2019
KRAS Mutation for Staging Resected Non-Small Cell Lung CancerMariana Canepa, Nimesh R Patel, Roger C Griffith, et al.
Pageof 10